M. Iversen (Copenhagen, Denmark), F. Meloni (Pavia, Italy)
Cytomegalovirus (CMV) infection – Correlation between CMV-DNA PCR in bronchoalveolar lavage (BAL), CMV pp65 antigen load in PBMCs and clinical symptoms in lung transplant recipients
U. Sommerwerck, T. Rabis, O. Anhenn, G. Weinreich, M. Kamler, N. Pizanis, H. Jakob, H. Teschler, U. Costabel (Essen, Germany)
|   |
Vitamin D deficiency in lung transplant patients: Is it important?
S. Verleden, R. Vos, S. Devleeschauwer, A. Vaneylen, L. Dupont, G. Verleden, D. Vanraemdonck, B. Vanaudenaerde (Leuven, Belgium)
| |
Association between CT and spirometric changes in azithromycin treatment of chronic lung allograft dysfunction
R. Vos, P. de Jong, S. Verleden, D. Van Raemdonck, L. Dupont, W. De Wever, J. Verschakelen, G. Verleden (Leuven, Belgium; Utrecht, Netherlands)
| |
CT findings before and after azithromycin treatment of chronic lung allograft dysfunction
R. Vos, P. de Jong, B. Vanaudenaerde, S. Verleden, D. Van Raemdonck, L. Dupont, W. De Wever, J. Verschakelen, G. Verleden (Leuven, Belgium; Utrecht, Netherlands)
| |
Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
J. Gottlieb, H. Suhling, J. Rademacher, T. Fuehner, T. Welte (Hannover, Germany)
| |
Bronchial carcinoma after lung transplantation, a sobering truth
J. Yserbyt, L. Dupont, D. Van Raemdonck, C. Dooms, G. Verleden (Leuven, Belgium)
| |
12 month follow-up of lung recipients with chronic allograft dysfunction treated with extracorporeal photopheresis (ECP)
N. Solari, V. Conio, T. Oggionni, C. Del Fante, C. Perotti, G. Viarengo, M. Morosini, S. Miserere, F. Meloni (Pavia, Italy)
| |
Inhaled tobramycin for the prevention of airway stenosis after lung transplantation: A pilot study
L. Yarmus, A. Shah, C. Merlo, J. Orens, D. Feller-Kopman, J. McDyer (Baltimore, United States Of America)
| |
Does single lung transplantation actually alleviate the donor pool?
A. Olland, N. Santelmo, P. E. Falcoz, C. Cantrelle, R. Dorent, G. Massard (Strasbourg, Saint Denis la Plaine, France)
| |
Recipient dependent factors for outcome in a twinned single lung transplantation model
A. Olland, N. Santelmo, B. Orsini, P. E. Falcoz, C. Cantrelle, R. Dorent, P. Thomas, G. Massard (Strasbourg, Marseille, Saint Denis la Plaine, France)
| |
Hyper expanded native lung treated with intra bronchial valves in single lung transplant recipients
M. Perch, E. Andersen, C. Jensen, J. Mortensen, M. Iversern (Copenhagen, Denmark)
| |
The use of a murine model of brain death for mechanistic studies on treatment for donor lung injury
S. Wauters, L. Lopopolo, E. Verbeken, C. Meers, J. van Loon, G. Verleden, D. Van Raemdonck (Leuven, Belgium)
| |
Determinant factors for bronchial ischemia after lung transplantation
A. Olland, N. Santelmo, P. E. Falcoz, G. Massard (Strasbourg, France)
| |
Transbronchial lung biopsy after lung transplantation: Different A and B scores in different lobes
P. Jaksch, A. Scheed, S. Geleff, G. Dekan, W. Klepetko (Vienna, Austria)
| |
Long term outcome of lung recipients bridged with extracorporeal devices
F. Meloni, C. Pellegrini, M. Belliato, M. Zanierato, A. Cascina, T. Oggionni, A. D‘Armini, G. Iotti, A. Braschi (Pavia, Italy)
| |
Management of total cicatricial stenoses of a trachea by replacement of trachea produced by technologies of the regenerative medicine
V. Parshin, P. Macchiarini, M. Vyjigina, M. Rusakov, D. Bazarov, H. Zaklyazminskaya (Moscow, Russian Federation; Stockholm, Sweden)
| |
Benefit of pulmonary rehabilitation in candidates for lung transplantation
M. G. Dierich, T. Fuehner, T. Welte, G. Warnecke, J. Gottlieb (Hannover, Germany)
| |